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PCI and follow up intravascular ultrasound (IVUS, mean 9.9±2.4 months) were
performed in all patients.
Results: The Post-PCI external elastic membrane (EEM) volume (group I vs group II,
417.3±196.5 vs 409.7±180.1 mm3, p=NS), post-PCI lumen volume (228.6±111.0 vs
223.0±89.5 mm3, p=NS), follow up EEM volume (435.1±168.1 vs 414.9±179.4 mm3,
p=NS), and follow up lumen volume (236.6±91.7 vs 222.5±90.1 mm3, p=NS) by IVUS
were not different between the two groups. There were three LISAs [2.5%, group I
(n=2) vs group II (n=1)] and thirty four PISAs [28.1%, group I (n=23) vs group II
(n=11)] that were resolved [14.7%, group I (n=4) vs group II (n=1)]. Post-PCI and
follow up volume of PISA was not significantly different in both group I (5.9±5.6 vs
5.1±4.6 mm3, p=NS) and group II (8.9±4.4 vs 8.5±4.2 mm3, p=NS). There was no
major adverse cardiac event associated with LISA or PISA during 12-month clinical
follow up.
Conclusion: The incidence of LISA was very low in both groups comparing to the
previous generation of drug eluting stent. Both LISA and PISA were not associated
with cardiac events during 12-month follow up. Future long-term follow up study to
clarify the clinical impacts of LISA and PISA would be needed.
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Background: We studied the long term outcome of patients with isolated proximal
LAD disease revascularised with either DES or ‘off-pump’ left internal mammary
artery (LIMA) graft.
Methods: 874 consecutive patients with stable angina undergoing either elective
percutaneous coronary intervention with a DES or ‘off-pump’CABG for significant
isolated proximal LAD disease at a London centre between Oct 2003-December 2010
were studied. The primary end point used was major adverse cardiac events (MACE),
defined as the composite of death, myocardial infarction (MI), stroke and target vessel
revascularization (TVR).
Results: 752 patients underwent PCI with DES and 122 pts underwent ‘off-pump’
CABG. The baseline demographic and angiographic characteristics were similar
between the two groups. The mean duration of hospitalization after CABG was 6.33
± 1.61 days vs. 1.06 ± 0.20 days after PCI (P < 0.001). Kaplan-Meier estimates of
major adverse cardiac events showed no differences between the groups over the
follow-up period (11.8% vs 12.0%, p=0.9 at 4 years) (Figure 1a). On MACE
breakdown there was a trend towards higher mortality in the LIMA cohort (7.8% vs
4.2%, p = 0.12) with a trend towards higher TVR in the DES group (5.8% vs 2.8%,
p=0.19) (Figure 1b). After multivariate adjustment revascularisation technique was not
predicative of major-adverse cardiac events.
Conclusion: The study demonstrated that DES have similar long-term results to LIMA
regarding MACE events in patients with isolated proximal LAD disease.
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Background: The aim of this study was to evaluate the frequency, predictors and the
clinical outcome of stent thrombosis after DES implantation and bare metal stent
(BMS) implantation in Asian races.
Methods: A total of 14,577 consecutive patients who underwent successful DES
implantation (8,809 patients, 62% of the lesion with Sirolimus-eluting stent: SES, 38%
of the lesion with Paclitaxel-eluting stent: PES) and BMS implantation (5,768 patients)
were included in this study. We evaluate the frequency, predictor of stent thrombosis.
Results: At a mean follow-up of 78.5±29.9 months in DES and 81.8±26.4 months in
BMS. The cumulative incidence of stent thrombosis were subacute stent thrombosis
(SAT): 0.5% with DES and 0.6% with BMS, late stent thrombosis (LAST): 0.18%
with DES and 0.1% with BMS, very late stent thrombosis (VLAST): 0.18% per year
with DES and no BMS. Independent predictors of stent thrombosis are bifurcation
lesion (OR=1.90, 95% CI: 1.83 to 24.24, p=0.01) and ejection fraction (OR=0.90, 95%
CI: 0.86 to 0.94, p=0.03). Only 0.2 % of the patients were died because of the
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